Dialaibo Biotechnology

China-based Dialaibo (Zhangjiagang) Biotechnology Co., Ltd has reportedly raised close to RMB 100 million (USD 13.7 million) in a Series A finance round. The round was led by Grand Yangtze Capital, with participation from Shulan Junjie Capital, Zhangjiagang Jinmao Venture Capital, Zhangjiagang Talent No.1 Fund, and Zhangjiagang Bonded Area Wisdom…